Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Guaraldi

Showing results (391-400 of 409) with videos related to

Pageof 41
Sort By:
Clinical and Experimental Nephrology|January 5, 2021
Hypokalemia in Patients with COVID-19Gaetano Alfano, Annachiara Ferrari, Francesco Fontana, et al.
Plos One|August 12, 2021
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state studyJovana Milic, Federico Banchelli, Marianna Meschiari, et al.
The Lancet Regional Health. Europe|June 10, 2026
Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver diseaseNicola Pugliese, Trenton M White, Paul N Brennan, et al.
The Lancet. Rheumatology|August 25, 2020
Tocilizumab in patients with severe COVID-19: a retrospective cohort studyGiovanni Guaraldi, Marianna Meschiari, Alessandro Cozzi-Lepri, et al.
Plos One|September 12, 2013
Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patientsLeonardo Potenza, Daniela Vallerini, Patrizia Barozzi, et al.
Rheumatology (Oxford, England)|September 24, 2020
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussionCaterina Vacchi, Marianna Meschiari, Jovana Milic, et al.
The New Microbiologica|November 12, 2014
Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical DiseaseOrlando Armignacco, Massimo Andreoni, Evangelista Sagnelli, et al.
Age and Ageing|May 21, 2026
Frailty and intrinsic capacity: integrating complementary concepts to promote healthy ageing and transformation of careMatteo Cesari, Marco Canevelli, Jotheeswaran Amuthavalli Thiyagarajan, et al.
The New Microbiologica|November 17, 2015
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim ProjectMassimo Andreoni, Simone Marcotullio, Vincenzo Puro, et al.
Plos One|November 12, 2020
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia-Challenges, strengths, and opportunities in a global health emergencyDavide Ferrari, Jovana Milic, Roberto Tonelli, et al.
Pageof 41

Showing results (391-400 of 409) with videos related to

Sort By:
Pageof 41
Clinical and Experimental Nephrology|January 5, 2021
Hypokalemia in Patients with COVID-19Gaetano Alfano, Annachiara Ferrari, Francesco Fontana, et al.
Plos One|August 12, 2021
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state studyJovana Milic, Federico Banchelli, Marianna Meschiari, et al.
The Lancet Regional Health. Europe|June 10, 2026
Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver diseaseNicola Pugliese, Trenton M White, Paul N Brennan, et al.
The Lancet. Rheumatology|August 25, 2020
Tocilizumab in patients with severe COVID-19: a retrospective cohort studyGiovanni Guaraldi, Marianna Meschiari, Alessandro Cozzi-Lepri, et al.
Plos One|September 12, 2013
Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patientsLeonardo Potenza, Daniela Vallerini, Patrizia Barozzi, et al.
Rheumatology (Oxford, England)|September 24, 2020
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussionCaterina Vacchi, Marianna Meschiari, Jovana Milic, et al.
The New Microbiologica|November 12, 2014
Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical DiseaseOrlando Armignacco, Massimo Andreoni, Evangelista Sagnelli, et al.
Age and Ageing|May 21, 2026
Frailty and intrinsic capacity: integrating complementary concepts to promote healthy ageing and transformation of careMatteo Cesari, Marco Canevelli, Jotheeswaran Amuthavalli Thiyagarajan, et al.
The New Microbiologica|November 17, 2015
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim ProjectMassimo Andreoni, Simone Marcotullio, Vincenzo Puro, et al.
Plos One|November 12, 2020
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia-Challenges, strengths, and opportunities in a global health emergencyDavide Ferrari, Jovana Milic, Roberto Tonelli, et al.
Pageof 41